COGT
Cogent Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$6.06B
P/E Ratio
—
EPS
$-2.16
Beta
0.47
52W High
$43.73
52W Low
$4.12
50-Day MA
$36.84
200-Day MA
$24.87
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Cogent Biosciences Inc
Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-121.63M |
| EBITDA | $-330.80M |
| Operating Margin | 0.00% |
| Return on Equity | -73.70% |
| Return on Assets | -32.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.40 |
| Price-to-Book | 10.45 |
| Price-to-Sales (TTM) | 861.15 |
| EV/Revenue | 929.31 |
| EV/EBITDA | -3.88 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $162.31M |
| Float | $150.97M |
| % Insiders | 0.30% |
| % Institutions | 107.68% |
Historical Volatility
HV 10-Day
72.43%
HV 20-Day
62.57%
HV 30-Day
53.11%
HV 60-Day
51.25%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($54.17 target)
2
Strong Buy9
Buy2
HoldData last updated: 4/10/2026